Results 101 to 110 of about 5,552,824 (295)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Plasmonic phase-gradient metasurface for spontaneous emission control [PDF]

open access: yes, 2015
We combine the concept of phase-gradient metasurfaces with fluorescence directionality control of an ensemble of incoherent emitters. We design a periodic metasurface to control the scattering amplitude of the lattice in momentum space.
Schokker, A.H.   +6 more
core   +1 more source

DataSheet1_Understanding of Wood Anomalies in Metallic Gratings From Phase Gradient Metasurfaces.docx

open access: yes, 2022
Phase-gradient metasurfaces (PGMs) have provided unprecedented opportunities for manipulating light. Here, we reexamine ordinary and well-studied subwavelength metallic gratings (OMGs) from the concept of PGMs to provide more insight into their ...
Jiaqi Quan (12478479)   +3 more
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Wideband Phase-Gradient Metasurface Antenna With Focused Beams

open access: yesIEEE Access, 2019
A transmitting lens antenna with focused beams by employing four-layer phase-gradient metasurface (PGMS) is proposed. A wideband slot-coupled antenna is mounted close to the focal position of the PGMS acting as a feed.
Jia-Jun Liang   +4 more
doaj   +1 more source

Correction of gradient-induced phase errors in radial MRI.

open access: yes, 2014
Purpose To correct gradient-induced phase errors in radial MRI. Methods Gradient-induced eddy currents affect the MRI data acquisition by gradient delays and phase errors that may lead to severe image artifacts for non-Cartesian imaging scenarios such as
Moussavi, A.   +11 more
core   +1 more source

Gradient estimates for Orlicz double phase problems with variable exponents

open access: yes, 2022
Baasandorj S, Byun S-S, Lee H-S. Gradient estimates for Orlicz double phase problems with variable exponents. Nonlinear Analysis.
Baasandorj, Sumiya   +5 more
core   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy